I-Repatha - umjovo we-evolocumab we-cholesterol

-Delile

• Intengo
• Yenzelwe ini
• Isetshenziswa kanjani
• Imiphumela emibi engaba khona
• Izimo eziphindaphindayo

I-Repatha ngumuthi wokujova oqukethe ukwakheka kwayo i-evolocumab, into esebenza esibindini esiza ukunciphisa amazinga we-cholesterol egazini.

Lo muthi ukhiqizwa ngama-laboratories e-Amgen ngesirinji egcwaliswe ngaphambili, efana nezibaya ze-insulin, ezingasetshenziswa ekhaya ngemuva kokuyalelwa udokotela noma umhlengikazi.

Intengo

I-Repatha, noma i-evolocumab, ingathengwa ezikhemisi ezethula incwadi kadokotela futhi inani layo lingahluka phakathi kwe-1400 reais, ngesirinji egcwaliswe ngaphambili engu-140 mg, kuya kuma-2400 reais, ngamasirinji ama-2.

Yenzelwe ini

I-Repatha ikhonjiswa ekwelashweni kweziguli ezinamazinga aphezulu e-cholesterol egazi abangelwa yi-hypercholesterolemia eyinhloko noma i-hypercholesterolemia exubile, futhi kufanele ihambisane nokudla okulinganiselayo njalo.

Isetshenziswa kanjani

Indlela yokusebenzisa i-Repatha, eyi-evolocumab, iqukethe umjovo ka-140 mg njalo emavikini amabili noma umjovo owodwa we-420 mg kanye ngenyanga. Kodwa-ke, umthamo ungalungiswa ngudokotela ngokomlando wezokwelapha.

Imiphumela emibi engaba khona

Imiphumela emibi ye-Repatha ifaka phakathi isifuba, ubomvu nokubamba kwesikhumba, ubunzima bokuphefumula, ukuphuma kwamakhala, umphimbo obuhlungu noma ukuvuvukala kobuso, isibonelo. Ngaphezu kwalokho, i-Repatha nayo ingadala ukusabela okweqile esizeni somjovo.

Izimo eziphindaphindayo

I-Repatha iyaphikisana neziguli ezine-hypersensitivity to evolocumab noma enye ingxenye yefomula.

Bheka futhi namathiphu kadokotela wezokudla on the best cholesterol-ukwehlisa ukudla: